You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Effect of ScanCap Technology on Medication Adherence and Hypertension Outcomes

    SBC: Concordance Health Solutions, Inc.            Topic: NIA

    DESCRIPTION (provided by applicant): In this Phase II SBIR project, Concordance Health Solutions (CHS) will continue development of the ScanCap System and test its effectiveness on adherence rates and hypertension patient outcomes The ScanCap System is anelectronic reminder cap that is seamlessly programmed at the pharmacy and incorporated into original packaging for prescription medications. The ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Obese diabetic (type II) mouse model without leptin/leptin-receptor defects

    SBC: PRECLINOMICS, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): An estimated 23.6 million people (7 percent of the population) in the United States have diabetes; 90 to 95 percent of all diagnosed cases are type 2 diabetes (CDC, 2007). Obesity and metabolic syndrome are the leadingcauses of type 2 diabetes. The search for new and more effective therapies to address the growing number of Americans with type 2 diabetes and re ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  3. Game FACTS (Fun, Adaptable-Content Trainer Suite): The Use of Microgames as a Sup

    SBC: WisdomTools Enterprises Inc            Topic: NIEHS

    DESCRIPTION: PROJECT SUMMARY/ABSTRACT. This Phase II SBIR project, Game FACTS (Fun, Adaptable-Content Trainer Suite): The Use of Microgames as a Supplemental Learning Tool for Worker Health and Safety Training builds upon the work of the previously fundedPhase I SBIR project Micro-games for WMD Training for Skilled Support Personnel. Phase I focused on the development of microgame (i.e., short-dur ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. System for Increasing Patient Access to Eye Exams for Diabetic Retinopathy

    SBC: AEON IMAGING LLC            Topic: NEI

    DESCRIPTION (provided by applicant): The overall goal of the proposed SBIR program is to implement and evaluate a low cost retinal camera, the Laser Scanning Digital Camera (LSDC), in a system for diabetic retinopathy (DR) screening. Untreated DR has reached epidemic levels in underserved populations worldwide. As the LSDC has already demonstrated its readiness for DR screening in preliminary stud ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  5. A Novel Approach for Real-time Proteomics in Live Cells

    SBC: POWERHOUSE PROTEOMIC SYSTEMS LLC            Topic: NCRR

    DESCRIPTION (provided by applicant): The ultimate goal of this SBIR project is to develop a novel proteomic system that will enable the real- time expression profiling of proteins in live murine embryonic stem (mES) cells and in differentiated cells derived there from. The first step involves the establishment of a library of fluorescent trap mES cell lines, each of which will harbor a single fluo ...

    SBIR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  6. Kidney Multiphoton Analysis of Therapeutic Agents

    SBC: INPHOTON, LLC            Topic: NIDDK

    DESCRIPTION (provided by applicant): The rate of drug development is disappointingly slow, in part because of the failure of preclinical drug studies to elucidate the mechanisms of drug actions. INphoton has demonstrated that intravital microscopy can be used as a powerful tool in preclinical drug studies, providing the mechanistic insights typically associated with studies of cultured cells, but ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  7. Separation Biosensor for Pharmacological Applications

    SBC: Bioanalytical Systems, Inc.            Topic: N/A

    The overall objective of this study is to develop a system that can be used to monitor pharmacokinepharmacological or neurochemical events in near real time. This will be accomplished by coupling micdirectly to capillary electrophoresis (CE). The system is much more versatile than conventional biossampling and analysis steps can be optimized separately. A system has been developed using CE with Ln ...

    SBIR Phase II 1997 Department of Health and Human Services
  8. Rapid Scanning Near-Infrared/Infrared Spectrometer

    SBC: En'urga Inc.            Topic: N/A

    This project involves a feasibility study for a rapid scanning near-infrared/infrared spectrometer for transient, simultaneous measurements of CO2 and H20 concentrations, soot volume fractions and temperatures. Such measurements can lead to improved understanding of the structure of turbulent and laminar flames. A commercial instrument that can reliably provide simultaneous gas concentrtaion, so ...

    SBIR Phase II 1997 Department of Commerce
  9. N/A

    SBC: ENDOCYTE, INC.            Topic: N/A

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  10. Method for Isolation and Microassay of Lipoprotein (A)

    SBC: MICRONIX, INC.            Topic: N/A

    Lipoprotein(a) [Lp(a)] has been labelled the most atherogenic lipoprotein in man. Current laboratorLp(a) employ immuno-quantitation of its apolipoprotein [apo(a)]. Because these methods are hamperedto plasminogen, apo(a) isoform dependence, antibody heterogeneity, and lack of standardization, noneapproved. One third of Lp(a)'s mass is cholesterol, and only one tenth is apo(a). We will develop ola ...

    SBIR Phase II 1997 Department of Health and Human Services
US Flag An Official Website of the United States Government